A comprehensive review of HPV vaccination policies in the United States
Frontiers in Public Health · 20.04.2026 · 14
DOI: 10.3389/fpubh.2026.1810845 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Public Health, online erschienen am 20.04.2026. Verfasst von Yathreb Bayan Mohamed und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Management and Systems Sciences, University of Louisville, Louisville, KY, United States. Hauptthemen laut MEDLINE: Papillomavirus Vaccines, Health Policy, Papillomavirus Infections, Vaccination. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: State of Kentucky Cabinet for Health and Family Services.
Abstract (Originalsprache)
Background
Human papillomavirus (HPV) is the leading cause of cervical cancer in the United States (U.S.), yet HPV vaccination coverage remains suboptimal and uneven across states. Policy approaches to improve HPV vaccine uptake vary widely across states in terms of health financing, provider authority, school requirements, and consent requirements.
Methods
A comprehensive review of state-level HPV vaccination policies was conducted. Information was identified through peer-reviewed literature (PubMed, Scopus, Google Scholar) and authoritative policy and legislative sources, including the Centers for Disease Control and Prevention, National Alliance of State Pharmacy Associations, National Academy for State Health Policy, and state statutes. Policies were categorized into macro-level health policies (Medicaid expansion, pharmacy and pharmacist authority, and state vaccine purchase programs) and HPV-specific policies (school-entry requirements, classroom sex education mandates, parental education mandates, minor consent laws, and exemption frameworks). Evidence on policy implementation and effectiveness was narratively synthesized.
Results
Substantial heterogeneity in HPV vaccination policy adoption and implementation across U.S. states was documented. Medicaid expansion, pharmacist vaccination authority, and well-enforced school-entry requirements were consistently associated with higher HPV vaccine initiation or completion, while policies with permissive exemptions or weak enforcement demonstrated limited impact. Financing mechanisms such as universal and selective vaccine purchase programs reduced cost barriers but showed inconsistent effects on uptake when implemented in isolation. Evidence suggests that no single policy is sufficient; multi-level, coordinated policy environments yield the greatest improvements in vaccination coverage.
Conclusion
HPV vaccination uptake in the U.S. is shaped by complex and interacting policy mechanisms rather than individual interventions. Integrated policy approaches that combine financing, access expansion, school-based strategies, provider engagement, and enforcement structures are most likely to achieve sustained and equitable improvements in HPV vaccine uptake.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Health Management and Systems Sciences, University of Louisville, Louisville, KY, United States.
Förderung
- State of Kentucky Cabinet for Health and Family Services
Zitieren
APA
Mohamed, Y. B., & Karimi, S. M. (2026). A comprehensive review of HPV vaccination policies in the United States. Frontiers in Public Health, 14. https://doi.org/10.3389/fpubh.2026.1810845
Vancouver
Mohamed YB, Karimi SM. A comprehensive review of HPV vaccination policies in the United States. Frontiers in Public Health. 2026;14. doi:10.3389/fpubh.2026.1810845
BibTeX
@article{Mohamed2026,
author = {Mohamed, Yathreb Bayan and Karimi, Seyed M},
title = {A comprehensive review of HPV vaccination policies in the United States},
journal = {Frontiers in Public Health},
year = {2026},
volume = {14},
doi = {10.3389/fpubh.2026.1810845}
}
EUVIMED